Accessibility Menu

ArcticZymes Technologies Asa(FRA) B4V

Market Cap€95.50MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€1.88
+0.27%
+0.00Today

ArcticZymes Technologies Asa Financials at a Glance

Market Cap

€95.50MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€11.02

Net Income (TTM)

€1.39

EPS (TTM)

€0.03

P/E Ratio

68.50

Dividend

€0.00

Beta (Volatility)

0.01 (Low)

Price

€1.88

Volume

0

Open

€1.88

Previous Close

€1.87

Daily Range

€1.88 - €1.88

52-Week Range

€1.57 - €2.62

Estimated Earnings Date

N/A

B4V News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ArcticZymes Technologies Asa

ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. It operates through the Enzymes and Corporate segments. The Enzymes segment is composed of sales revenues and operating expenses associated with the subsidiary ArcticZymes AS, which develops and markets recombinant enzymes for use in life science research, molecular diagnostics, and bio-manufacturing. The Corporate segment provides a range of administrative services to the subsidiary. The company was founded by Jan Raa and Gunnar Rorstad in November 1990 and is headquartered in Tromso, Norway.

Industry

Biotechnology

Sector

Health Care

Employees

50.9

CEO

Michael B. Akoh

Website

www.arcticzymes.com

B4V Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

4.79%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

1.46%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€95.50MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

51.07M

Volume

0

Avg. Volume

142.424

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

ArcticZymes Technologies Asa Performance Analysis

ArcticZymes Technologies Asa annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 13,546,6457.6%
20232023-12-31EUR 10,407,782-23.2%
20242024-12-31EUR 8,970,227-13.8%
20252025-12-31EUR 9,609,6837.1%
ArcticZymes Technologies Asa annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 0.06-29.3%
20232023-12-31EUR 0.03-47.6%
20242024-12-31EUR 0.01-57.2%
20252025-12-31EUR 0.0214.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€2.91

+1.3%

Gross Profit

€1.09

+1.4%

Gross Margin

37.41%

+1.1%

Market Cap

€95.50MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€1.74

N/A

Employees

50.9

N/A

Net Income

€0.48

+1.7%

EBITDA

€0.68

+2.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€18.45

+22.5%

Total Debt

€1.63

+2.7%

Accounts Receivable

€1.66

+1.1%

Inventory

€1.29

+0.9%

Long Term Debt

€1.29

+3.3%

Short Term Debt

€0.35

+1.7%

Return on Assets

4.43%

+8.1%

Return on Invested Capital

8.14%

+0.6%

Free Cash Flow

€0.43

+0.9%

Operating Cash Flow

€0.72

+1.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About B4V

What is the current price of ArcticZymes Technologies Asa?

ArcticZymes Technologies Asa is trading at €1.88 per share.

What is the 52-week range for ArcticZymes Technologies Asa?

Over the past 52 weeks, ArcticZymes Technologies Asa has traded between €1.57 and €2.62.

How much debt does ArcticZymes Technologies Asa have?

As of the most recent reporting period, ArcticZymes Technologies Asa reported total debt of €1.63M.

How much cash does ArcticZymes Technologies Asa have on hand?

ArcticZymes Technologies Asa reported €16.82M in cash and cash equivalents in its most recent financial results.

What is ArcticZymes Technologies Asa’s dividend yield?

ArcticZymes Technologies Asa does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services